| C3 glomerulopathy: consensus report MC Pickering, VD D'agati, CM Nester, RJ Smith, M Haas, GB Appel, ... Kidney international 84 (6), 1079-1089, 2013 | 695 | 2013 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 652 | 2017 |
| Systemic lupus erythematosus, complement deficiency, and apoptosis MC Pickering, M Botto, PR Taylor, PJ Lachmann, MJ Walport Advances in immunology 76, 227-324, 2001 | 614 | 2001 |
| Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H MC Pickering, HT Cook, J Warren, AE Bygrave, J Moss, MJ Walport, ... Nature genetics 31 (4), 424-428, 2002 | 594 | 2002 |
| Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation MK Liszewski, M Kolev, G Le Friec, M Leung, PG Bertram, AF Fara, ... Immunity 39 (6), 1143-1157, 2013 | 535 | 2013 |
| C3 glomerulopathy: a new classification F Fakhouri, V Frémeaux-Bacchi, LH Noël, HT Cook, MC Pickering Nature Reviews Nephrology 6 (8), 494-499, 2010 | 449 | 2010 |
| Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis DP Gale, EG De Jorge, HT Cook, R Martinez-Barricarte, A Hadjisavvas, ... The Lancet 376 (9743), 794-801, 2010 | 373 | 2010 |
| Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains MC Pickering, EG de Jorge, R Martinez-Barricarte, S Recalde, ... The Journal of experimental medicine 204 (6), 1249-1256, 2007 | 338 | 2007 |
| New approaches to the treatment of dense deposit disease RJH Smith, J Alexander, PN Barlow, M Botto, TL Cassavant, HT Cook, ... Journal of the American Society of Nephrology 18 (9), 2447-2456, 2007 | 332 | 2007 |
| Complement in human diseases: lessons from complement deficiencies M Botto, M Kirschfink, P Macor, MC Pickering, R Würzner, F Tedesco Molecular immunology 46 (14), 2774-2783, 2009 | 324 | 2009 |
| Atypical aHUS: state of the art CM Nester, T Barbour, SR de Cordoba, MA Dragon-Durey, ... Molecular immunology 67 (1), 31-42, 2015 | 314 | 2015 |
| Dimerization of complement factor H-related proteins modulates complement activation in vivo E Goicoechea de Jorge, JJE Caesar, TH Malik, M Patel, M Colledge, ... Proceedings of the National Academy of Sciences 110 (12), 4685-4690, 2013 | 301 | 2013 |
| C3 glomerulopathy—understanding a rare complement-driven renal disease RJH Smith, GB Appel, AM Blom, HT Cook, VD D’Agati, F Fakhouri, ... Nature reviews nephrology 15 (3), 129-143, 2019 | 300 | 2019 |
| Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference J Floege, SJ Barbour, DC Cattran, JJ Hogan, PH Nachman, SCW Tang, ... Kidney international 95 (2), 268-280, 2019 | 273 | 2019 |
| C3 glomerulopathy: clinicopathologic features and predictors of outcome NR Medjeral-Thomas, MM O’Shaughnessy, JA O’Regan, C Traynor, ... Clinical Journal of the American Society of Nephrology 9 (1), 46-53, 2014 | 267 | 2014 |
| C1q deficiency and autoimmunity: the effects of genetic background on disease expression DA Mitchell, MC Pickering, J Warren, L Fossati-Jimack, ... The Journal of Immunology 168 (5), 2538-2543, 2002 | 260 | 2002 |
| Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction PJ Coffey, C Gias, CJ McDermott, P Lundh, MC Pickering, C Sethi, A Bird, ... Proceedings of the National Academy of Sciences 104 (42), 16651-16656, 2007 | 248 | 2007 |
| Links between complement abnormalities and systemic lupus erythematosus MC Pickering, MJ Walport Rheumatology 39 (2), 133-141, 2000 | 230 | 2000 |
| Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals MC Pickering, HT Cook Clinical & Experimental Immunology 151 (2), 210-230, 2008 | 225 | 2008 |
| C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation A Tortajada, H Yébenes, C Abarrategui-Garrido, J Anter, ... The Journal of clinical investigation 123 (6), 2434-2446, 2013 | 207 | 2013 |
